By Admin 
A scientific party is researching a new type of antibody, which activates cancer cells by activating the body’s immunity system and slows down the growth of the tumor of the breast and ovary cancer in spite of treatment. An antibodies called IGG are used as immunotherapy. It helps the body’s immune system fight cancer and is considered an alternative to chemotherapy and radiotherapy. However, this treatment is not effective in some patients, especially in breast and ovary cancer, and sometimes the body develops immunity to this treatment.
London scientists conducted research
Kings College London scientists researched a different types of types of antibodies called IGE. This antibody activates the immune system in a different way from IGG. IgE antibodies awaken the immune cells of the body that are usually not active and are present around the tumor. This makes cancer cells directly targeted.
Research revealed this matter
Researchers prepared IGE antibodies instead of IGG antibodies and tested it. Researcher Dr. Heather Bax, King’s College London, said IGE activated the immune system against cancer cells affected by HER2 and slowed down the growth of tumors in mice. This tumor was developed in mice that do not have the effect of traditional treatment. This indicates that this new technology can be beneficial for patients on which the current treatment does not work.
These cancer patients will benefit
further and on studying, scientists found that IGE antibody could re -activate the immune system around the tumor. This increases the immune system’s ability to fight cancer. This research has been published in the Journal for Immunotherapy of Cancer (JITC). According to Dr. Heather Bax, "About 20% of a marker called HER2 is found in breast and ovary cancer. We prepared an IGE antibody against HER2 and found that it could activate the immune system in a new way. This can effectively target HER2 cancer cells, especially in cases where the existing treatment does not work."& nbsp; He further stated that this new discovery can become a new treatment option for patients suffering from HER2 cancer.
Read also: After brushing in the morning, forget these important tasks? May be big loss